Extracorporeal shock wave therapy for digital ulcers of systemic sclerosis: A phase 2 pilot study

Tohoku Journal of Experimental Medicine

Volumn 238, Issue 1, 2015, Pages 39-47

  Saito, Shinichiro ^a   Ishii, Tomonori ^a   Kamogawa, Yukiko ^a   Watanabe, Ryu ^a   Shirai, Tsuyoshi ^a   Fujita, Yoko ^a   Shirota, Yuko ^a   Fujii, Hiroshi ^a   Ito, Kenta ^a   Shimokawa, Hiroaki ^a   Yamaguchi, Takuhiro ^a   Kawaguchi, Yasushi ^b   Harigae, Hideo ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Digital ulcer; Extracorporeal shock wave therapy; Neovascularization; Raynaud s phenomenon; Systemic sclerosis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; DISEASE ASSOCIATION; EUROQOL 5 DIMENSION; EXTRACORPOREAL LITHOTRIPSY; FEMALE; FINGER ULCER; FUNCTIONAL ASSESSMENT; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MALE; MINIMALLY INVASIVE PROCEDURE; PHASE 2 CLINICAL TRIAL; PILOT STUDY; SAFETY; SKIN SURFACE; SKIN TEMPERATURE; SYSTEMIC SCLEROSIS; THERAPY EFFECT; THERMOGRAPHY; ULCER HEALING; VISUAL ANALOG SCALE; ADVERSE EFFECTS; CLINICAL TRIAL; COMPLICATION; ELASTICITY; FINGER; LITHOTRIPSY; MIDDLE AGED; PAIN; PATHOLOGY; QUALITY OF LIFE; SKIN ULCER; TEMPERATURE; WOUND HEALING;

ADULT; AGED; ELASTICITY; FEMALE; FINGERS; HUMANS; LITHOTRIPSY; MALE; MIDDLE AGED; PAIN; PILOT PROJECTS; QUALITY OF LIFE; SCLERODERMA, SYSTEMIC; SKIN ULCER; TEMPERATURE; WOUND HEALING;

EID: 84951071670     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.238.39     Document Type: Article

References (26)

1. Abraham, D.J. & Varga, J. (2005) Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol., 26, 587-595.
2. Aicher, A., Heeschen, C., Sasaki, K., Urbich, C., Zeiher, A.M. & Dimmeler, S. (2006) Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation, 114, 2823-2830.
3. Carvalho, J.F., Blank, M. & Shoenfeld, Y. (2007) Vascular endothelial growth factor (VEGF) in autoimmune diseases. J. Clin. Immunol., 27, 246-256.
4. Cerinic, M.M., Valentini, G., Sorano, G.G., D’Angelo, S., Cuomo, G., Fenu, L., Generini, S., Cinotti, S., Morfini, M., Pignone, A., Guiducci, S., Del Rosso, A., Kalfin, R., Das, D. & Marongiu, F. (2003) Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis. Semin. Arthritis Rheum., 32, 285-295.
5. Cherkas, L.F., Carter, L., Spector, T.D., Howell, K.J., Black, C.M. & MacGregor, A.J. (2003) Use of thermographic criteria to identify Raynaud’s phenomenon in a population setting. J. Rheumatol., 30, 720-722.
6. Ciampa, A.R., de Prati, A.C., Amelio, E., Cavalieri, E., Persichini, T., Colasanti, M., Musci, G., Marlinghaus, E., Suzuki, H. & Mariotto, S. (2005) Nitric oxide mediates anti-inflammatory action of extracorporeal shock waves. FEBS Lett., 579, 6839-6845.
7. Clements, P.J., Lachenbruch, P.A., Seibold, J.R., Zee, B., Steen, V.D., Brennan, P., Silman, A.J., Allegar, N., Varga, J., Massa, M., Wigley, F.M., Ingenito, F., Weisman, M., White, B., Martin R.W., et al. (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J. Rheumatol., 20, 1892-1896.
8. Denton, C.P. & Black, C.M. (2005) Targeted therapy comes of age in scleroderma. Trends Immunol., 26, 596-602.
9. Fukumoto, Y., Ito, A., Uwatoku, T., Matoba, T., Kishi, T., Tanaka, H., Takeshita, A., Sunagawa, K. & Shimokawa, H. (2006) Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coron. Artery Dis., 17, 63-70.
10. García Peña-Lefebvre, P., Rodríguez Rubio, S., Valero Expósito, M., Carmona, L., Gámir Gámir, M.L., Beltrán Gutiérrez, J., Díaz-Miguel, C., Orte Martínez, J. & Zea Mendoza, A.C. (2008) Long-term experience of bosentan for treating ulcers and healed ulcers in systemic sclerosis patients. Rheumatology, 47, 464-466.
11. Guiducci, S., Giacomelli, R. & Cerinic, M.M. (2007) Vascular complications of scleroderma. Autoimmun. Rev., 6, 520-523.
12. Hayashi, D., Kawakami, K., Ito, K., Ishii, K., Tanno, H., Imai, Y., Kanno, E., Maruyama, R., Shimokawa, H. & Tachi, M. (2012) Low-energy extracorporeal shock wave therapy enhances skin wound healing in diabetic mice: a critical role of endothelial nitric oxide synthase. Wound Repair Regen., 20, 887-895.
13. Ito, K., Fukumoto, Y. & Shimokawa, H. (2009) Extracorporeal shock wave therapy as a new and non-invasive angiogenic strategy. Tohoku J. Exp. Med., 219, 1-9.
14. Khimdas, S., Harding, S., Bonner, A., Zummer, B., Baron, M. & Pope, J. (2011) Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry. Arthritis Care Res., 63, 142-149.
15. Kikuchi, Y., Ito, K., Ito, Y., Shiroto, T., Tsuburaya, R., Aizawa, K., Hao, K., Fukumoto, Y., Takahashi, J., Takeda, M., Nakayama, M., Yasuda, S., Kuriyama, S., Tsuji, I. & Shimokawa, H. (2010) Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris. Circ. J., 74, 589-591.
16. Korn, J.H., Mayes, M., Matucci Cerinic, M., Rainisio, M., Pope, J., Hachulla, E., Rich, E., Carpentier, P., Molitor, J., Seibold, J.R., Hsu, V., Guillevin, L., Chatterjee, S., Peter, H.H., Coppock, J., et al. (2004) Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum., 50, 3985-3993.
17. Mariotto, S., Cavalieri, E., Amelio, E., Ciampa, A.R., de Prati, A.C., Marlinghaus, E., Russo, S. & Suzuki, H. (2005) Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO production. Nitric Oxide, 12, 89-96.
18. Matsumura, H., Imai, R., Gondo, M. & Watanabe, K. (2012) Evaluation of pain intensity measurement during the removal of wound dressing material using ‘the PainVision™ system’ for quantitative analysis of perception and pain sensation in healthy subjects. Int. Wound J., 9, 451-455.
19. Matucci-Cerinic, M., Denton, C.P., Furst, D.E., Mayes, M.D., Hsu, V.M., Carpentier, P., Wigley, F.M., Black, C.M., Fessler, B.J., Merkel, P.A., Pope, J.E., Sweiss, N.J., Doyle, M.K., Hellmich, B., Medsger, T.A. Jr., et al. (2011) Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Ann. Rheum. Dis., 70, 32-38.
20. Moretti, B., Notarnicola, A., Maggio, G., Moretti, L., Pascone, M., Tafuri, S. & Patella, V. (2009) The management of neuropathic ulcers of the foot in diabetes by shock wave therapy. BMC Musculoskelet. Disord., 10, 54.
21. Nishida, T., Shimokawa, H., Oi, K., Tatewaki, H., Uwatoku, T., Abe, K., Matsumoto, Y., Kajihara, N., Eto, M., Matsuda, T., Yasui, H., Takeshita, A. & Sunagawa, K. (2004) Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation, 110, 3055-3061.
22. Poole, J.L., Watzlaf, V.J. & D’amico, F. (2004) A five-year followup of hand function and activities of daily living in systemic sclerosis (scleroderma). J. Hand Ther., 17, 407-411.
23. Schaden, W., Thiele, R., Kölpl, C., Pusch, M., Nissan, A., Attinger, C.E., Maniscalco-Theberge, M.E., Peoples, G.E., Elster, E.A. & Stojadinovic, A. (2007) Shock wave therapy for acute and chronic soft tissue wounds: a feasibility study. J. Surg. Res., 143, 1-12.
24. Steen, V., Denton, C.P., Pope, J.E. & Matucci-Cerinic, M. (2009) Digital ulcers: overt vascular disease in systemic sclerosis. Rheumatology (Oxfod), 48 Suppl 3, iii19-24. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum., 23, 581-590.
25. Tinazzi, E., Amelio, E., Marangoni, E., Guerra, C., Puccetti, A., Codella, O.M., Simeoni, S., Cavalieri, E., Montagnana, M., Adani, R., Corrocher, R. & Lunardi, C. (2011) Effects of shock wave therapy in the skin of patients with progressive systemic sclerosis: a pilot study. Rheumatol. Int., 31, 651-656.
26. van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S.R., Baron, M., Tyndall, A., Matucci-Cerinic, M., Naden, R.P., Medsger, T.A, Carreira, P.E., Riemekasten, G., Clements, P.J., Denton, C.P., Distler, O., Allanore, Y., et al. (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum., 65, 2737-2747.